Status:
RECRUITING
Validation of Chronic Obstructive Pulmonary Disease (COPD) Algorithm
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
COPD (Chronic Obstructive Pulmonary Disease)
Eligibility:
All Genders
40+ years
Brief Summary
Under-diagnosis of Chronic Obstructive Pulmonary Disease (COPD) is prevalent, with an estimated 75% of adults suffering from COPD in the US, without clinical recognition. Often, the first diagnosis of...
Detailed Description
Guideline based therapy for COPD includes bronchodilators in conjunction with smoking cessation, vaccination and pulmonary rehabilitation. Bronchodilators have repeatedly been shown to improve symptom...
Eligibility Criteria
Inclusion
- greater thank or equal to 40 years of age
- 2 or more encounters in the health system
- Previous Pulmonary Function Test (PFT) recorded in our Electronic Health Records (EHR) in the previous 5 years
Exclusion
- cystic fibrosis
- Alpha-1 Antitrypsin Deficiency (AAD)currently pregnant
- History of a lung transplant or partial removal of the lung
- significant chest wall deformity
- neuromuscular disease that currently impacts the respiratory muscles
- surgery requiring general anesthesia or an overnight stay in the hospital within the past 30 days
Key Trial Info
Start Date :
August 22 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT07223749
Start Date
August 22 2025
End Date
December 30 2026
Last Update
November 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Health Sciences
Winston-Salem, North Carolina, United States, 27157